David A. Peake
Thermo Fisher Scientific
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David A. Peake.
Journal of Lipid Research | 2017
John A. Bowden; Alan Heckert; Candice Z. Ulmer; Christina M. Jones; Jeremy P. Koelmel; Laila Abdullah; Linda Ahonen; Yazen Alnouti; Aaron M. Armando; John M. Asara; Takeshi Bamba; John R. Barr; Jonas Bergquist; Christoph H. Borchers; Joost Brandsma; Susanne B. Breitkopf; Tomas Cajka; Amaury Cazenave-Gassiot; Antonio Checa; Michelle A. Cinel; Romain A. Colas; Serge Cremers; Edward A. Dennis; James E. Evans; Alexander Fauland; Oliver Fiehn; Michael S. Gardner; Timothy J. Garrett; Katherine H. Gotlinger; Jun Han
As the lipidomics field continues to advance, self-evaluation within the community is critical. Here, we performed an interlaboratory comparison exercise for lipidomics using Standard Reference Material (SRM) 1950–Metabolites in Frozen Human Plasma, a commercially available reference material. The interlaboratory study comprised 31 diverse laboratories, with each laboratory using a different lipidomics workflow. A total of 1,527 unique lipids were measured across all laboratories and consensus location estimates and associated uncertainties were determined for 339 of these lipids measured at the sum composition level by five or more participating laboratories. These evaluated lipids detected in SRM 1950 serve as community-wide benchmarks for intra- and interlaboratory quality control and method validation. These analyses were performed using nonstandardized laboratory-independent workflows. The consensus locations were also compared with a previous examination of SRM 1950 by the LIPID MAPS consortium. While the central theme of the interlaboratory study was to provide values to help harmonize lipids, lipid mediators, and precursor measurements across the community, it was also initiated to stimulate a discussion regarding areas in need of improvement.
Diabetes | 2015
Michelle B. Trevino; Yui Machida; Daniel R. Hallinger; Eden Garcia; Aaron Christensen; Sucharita Dutta; David A. Peake; Yasuhiro Ikeda; Yumi Imai
Elevation of circulating fatty acids (FA) during fasting supports postprandial (PP) insulin secretion that is critical for glucose homeostasis and is impaired in diabetes. We tested our hypothesis that lipid droplet (LD) protein perilipin 5 (PLIN5) in β-cells aids PP insulin secretion by regulating intracellular lipid metabolism. We demonstrated that PLIN5 serves as an LD protein in human islets. In vivo, Plin5 and triglycerides were increased by fasting in mouse islets. MIN6 cells expressing PLIN5 (adenovirus [Ad]-PLIN5) and those expressing perilipin 2 (PLIN2) (Ad-PLIN2) had higher [3H]FA incorporation into triglycerides than Ad-GFP control, which support their roles as LD proteins. However, Ad-PLIN5 cells had higher lipolysis than Ad-PLIN2 cells, which increased further by 8-Br-cAMP, indicating that PLIN5 facilitates FA mobilization upon cAMP stimulation as seen postprandially. Ad-PLIN5 in islets enhanced the augmentation of glucose-stimulated insulin secretion by FA and 8-Br-cAMP in G-protein–coupled receptor 40 (GPR40)- and cAMP-activated protein kinase–dependent manners, respectively. When PLIN5 was increased in mouse β-cells in vivo, glucose tolerance after an acute exenatide challenge was improved. Therefore, the elevation of islet PLIN5 during fasting allows partitioning of FA into LD that is released upon refeeding to support PP insulin secretion in cAMP- and GPR40-dependent manners.
Analytical Chemistry | 2018
Evelyn Rampler; Angela Criscuolo; Martin Zeller; Yasin El Abiead; Harald Schoeny; Gerrit Hermann; Elena Sokol; Ken Cook; David A. Peake; Bernard Delanghe; Gunda Koellensperger
Lipid identification and quantification are essential objectives in comprehensive lipidomics studies challenged by the high number of lipids, their chemical diversity, and their dynamic range. In this work, we developed a tailored method for profiling and quantification combining (1) isotope dilution, (2) enhanced isomer separation by C30 fused-core reversed-phase material, and (3) parallel Orbitrap and ion trap detection by the Orbitrap Fusion Lumos Tribid mass spectrometer. The combination of parallelizable ion analysis without time loss together with different fragmentation techniques (HCD/CID) and an inclusion list led to higher quality in lipid identifications exemplified in human plasma and yeast samples. Moreover, we used lipidome isotope-labeling of yeast (LILY)-a fast and efficient in vivo labeling strategy in Pichia pastoris-to produce (nonradioactive) isotopically labeled eukaryotic lipid standards in yeast. We integrated the 13C lipids in the LC-MS workflow to enable relative and absolute compound-specific quantification in yeast and human plasma samples by isotope dilution. Label-free and compound-specific quantification was validated by comparison against a recent international interlaboratory study on human plasma SRM 1950. In this way, we were able to prove that LILY enabled quantification leads to accurate results, even in complex matrices. Excellent analytical figures of merit with enhanced trueness, precision and linearity over 4-5 orders of magnitude were observed applying compound-specific quantification with 13C-labeled lipids. We strongly believe that lipidomics studies will benefit from incorporating isotope dilution and LC-MSn strategies.
Analytical Chemistry | 1985
David A. Peake; Michael L. Gross
Analytical Chemistry | 1985
David A. McCrery; David A. Peake; Michael L. Gross
Journal of the American Chemical Society | 1984
David A. Peake; Michael L. Gross; D. P. Ridge
Journal of the American Chemical Society | 1987
Christian Schulze; Helmut Schwarz; David A. Peake; Michael L. Gross
Analytical Chemistry | 1987
David A. Peake; S. K. Huang; Michael L. Gross
Journal of the American Chemical Society | 1987
David A. Peake; Michael L. Gross
Organometallics | 1986
David A. Peake; Michael L. Gross